SciSparc put in C$2.7 million, half the total, and says it will hold approximately 44.6% of NeuroThera afterward. NeuroThera plans to use the money for general working capital.
NeuroThera would issue 56,600,000 of its own shares, valued at approximately $9,459,954.20, plus up to $2,500,000 in earn-out payments. The release does not say what the issuance would do to SciSparc's approximately 75% stake in NeuroThera.
Questions about NeuroThera Labs
What is the ticker symbol of NeuroThera Labs?
NeuroThera Labs Inc. trades under the ticker NTLX on TSXV.
Where is NeuroThera Labs listed?
NeuroThera Labs Inc. is listed on TSXV.
Which country or territory is NeuroThera Labs listed under?
Our directory records NeuroThera Labs Inc. under Canada.
What does NeuroThera Labs do?
Our directory classifies NeuroThera Labs Inc. as: Clinical-stage CNS drugs. This is a directory classification, not a description of the pipeline.
What is the ISIN of NeuroThera Labs?
The ISIN recorded for NeuroThera Labs Inc. is CA64136J2002.
Does aibio.space cover NeuroThera Labs?
aibio.space lists NeuroThera Labs Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Which other companies' news mentions NeuroThera Labs?
NeuroThera Labs is named in 2 of our stories about other companies, most recently: "SciSparc unit NeuroThera Labs completes C$5.4 million private placements" (Aug 18, 2026); "SciSparc unit NeuroThera Labs to buy 54.01% of CliniQuantum for shares" (Mar 12, 2026). Source.
Which companies are similar to NeuroThera Labs?
Companies in our directory listed in the same country and business area as NeuroThera Labs: Neural Therapeutics, Resverlogix, ZYUS Life Sciences, Defence Therapeutics, Rapid Dose Therapeutics, Genix Pharmaceuticals.
How can I follow NeuroThera Labs (NTLX) news?
Press Follow on this page to add NeuroThera Labs to your Following list, or subscribe to the aibio.space newsletter. We have published 2 stories naming NeuroThera Labs so far, in Financings, Mergers.
Investor discussion: NeuroThera Labs
Members talk about NeuroThera Labs (NTLX). Reader posts, not aibio.space reporting, and not investment advice.
Rules
Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.
Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.
Stock chart
Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TSXV:NTLX on TradingView.
Listing details
NeuroThera Labs Inc. is a public biotech or pharmaceutical company listed on TSXV under the ticker NTLX, recorded under Canada. The directory classifies it as Clinical-stage CNS drugs. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.
Published and maintained by aibio.space. Not investment advice. How we work.
Who manages this pageThis page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio